The impact of combined inhaled bronchodilator therapy in the treatment of COPD
Background: Treatment guidelines recommend concomitantuse of ipratropium bromide and
inhaled β 2-agonists asseverity of COPD progresses. While the use of these two agents in …
inhaled β 2-agonists asseverity of COPD progresses. While the use of these two agents in …
[PDF][PDF] The impact of comblneâ inhaîeâ bronchodilator therapy in the treatment of COPD
S Benayoun - 1998 - nlc-bnc.ca
The introduction of a single inhaler comprising a C-agonist and ipratropium (~ ombivent@)
in the treatment of Chronic Obstructive Pulmonary Disease (COPD) should enhance …
in the treatment of Chronic Obstructive Pulmonary Disease (COPD) should enhance …
[引用][C] The impact of combined inhaled bronchodilator therapy in the Treatment of COPD
S BENAYOUN, P ERNST, S SUISSA - Chest, 2001 - pascal-francis.inist.fr
The impact of combined inhaled bronchodilator therapy in the Treatment of COPD CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
The impact of combined inhaled bronchodilator therapy in the treatment of COPD.
S Benayoun, P Ernst, S Suissa - Chest, 2001 - europepmc.org
Background Treatment guidelines recommend concomitant use of ipratropium bromide and
inhaled beta2-agonists as severity of COPD progresses. While the use of these two agents …
inhaled beta2-agonists as severity of COPD progresses. While the use of these two agents …
The Impact of Combined Inhaled Bronchodilator Therapy in the Treatment of COPD
S Benayoun, P Ernst, S Suissa - Chest, 2001 - go.gale.com
Background: Treatment guidelines recommend concomitant use of ipratropium bromide and
inhaled [[Beta]. sub. 2]-agonists as severity of COPD progresses. While the use of these two …
inhaled [[Beta]. sub. 2]-agonists as severity of COPD progresses. While the use of these two …
[引用][C] The impact of combined inhaled bronchodilator therapy in the treatment of COPD.
S Benayoun - 2000 - elibrary.ru
Degree: M. Sc. DegreeYear: 1999 Institute: McGill University (Canada) Adviser: Samy
Suissa. The introduction of a single inhaler comprising a β 2-agonist and ipratropiurn …
Suissa. The introduction of a single inhaler comprising a β 2-agonist and ipratropiurn …
The impact of combined inhaled bronchodilator therapy in the treatment of COPD
S Benayoun - 1998 - library-archives.canada.ca
INFORMATION TO USERS Page 1 INFORMATION TO USERS This manuscript has been
reproduced from the microfilm master. UMI films the text directly from the original or copy …
reproduced from the microfilm master. UMI films the text directly from the original or copy …
The Impact of Combined Inhaled Bronchodilator Therapy in the Treatment of COPD
S Benayoun, P Ernst, S Suissa - CHEST, 2001 - journal.chestnet.org
Background: Treatment guidelines recommend concomitantuse of ipratropium bromide and
inhaled β 2-agonists asseverity of COPD progresses. While the use of these two agents in …
inhaled β 2-agonists asseverity of COPD progresses. While the use of these two agents in …
The impact of combined inhaled bronchodilator therapy in the treatment of COPD
S Benayoun - 1998 - escholarship.mcgill.ca
The introduction of a single inhaler comprising a beta2-agonist and ipratropiurn
(CombiventRTM) in the treatment of Chronic Obstructive Pulmonary Disease (COPD) should …
(CombiventRTM) in the treatment of Chronic Obstructive Pulmonary Disease (COPD) should …
The impact of combined inhaled bronchodilator therapy in the treatment of COPD
S Benayoun, P Ernst, S Suissa - Chest, 2001 - search.proquest.com
BACKGROUND: Treatment guidelines recommend concomitant use of ipratropium bromide
and inhaled beta2-agonists as severity of COPD progresses. While the use of these two …
and inhaled beta2-agonists as severity of COPD progresses. While the use of these two …